Svp Global Marketing And Us Commercialization
CurrentThe NGAL biomarker rises within 2-4 hours of insult to the kidney; the assay from BioPorto is CE Marked in Europe with availability extended across the globe to South Korea, approved in Canada, and with an active clinical trial in the USA of our RUO offering on automated clinical chemistry. We are pleased to support the clinical researchers around the global using NGAL to determine which patients, when and how to modify fluid and nephrotoxin management when Acute Kidney Injury (AKI) can be… Show more The NGAL biomarker rises within 2-4 hours of insult to the kidney; the assay from BioPorto is CE Marked in Europe with availability extended across the globe to South Korea, approved in Canada, and with an active clinical trial in the USA of our RUO offering on automated clinical chemistry. We are pleased to support the clinical researchers around the global using NGAL to determine which patients, when and how to modify fluid and nephrotoxin management when Acute Kidney Injury (AKI) can be identified. Show less